Oligodendrocyte gene expression in the human fetal spinal cord during the second trimester of gestation

William E. Grever, Karen M. Weidenheim, Marianela Tricoche, William K. Rashbaum, William D. Lyman

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A comprehensive evaluation of myelination during normal human development is essential to understand the pathology of congenital diseases of white matter. The present study establishes quantitative values for normal oligodendrocyte-specific gene expression during the early stages of myelination in the human fetal spinal cord. Complementary techniques of Northern and immunoblotting were used to determine relative amounts of oligodendrocyte-specific mRNAs and proteins between 12 and 24 gestational weeks. Values were determined for myelin basic protein, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and proteolipid protein. The relative amount of myelin-associated glycoprotein mRNA was also estimated. To compare gene expression between glial cell types, the relative amounts of mRNA and protein were determined for glial fibrillary acidic protein (GFAP), a cell-type specific marker for astrocytes. All oligodendrocyte-specific genes expressed similar developmental kinetics. Between 12 and 15 gestational weeks, less than a five-fold increase was detected in the expression of these genes and their protein products. Between 15 and 22 gestational weeks, the relative amounts of mRNA and protein for the myelin genes increased more than 80- fold. The kinetics of GFAP expression were similar to those of the myelin- associated genes. Absolute values for the increase in mass of the human fetal spinal cord were also obtained. These results provide data that may aid in the neuropathologic assessment and characterization of myelin disorders in the preterm, neonatal, and pediatric spinal cord.

Original languageEnglish (US)
Pages (from-to)332-340
Number of pages9
JournalJournal of Neuroscience Research
Volume47
Issue number3
DOIs
StatePublished - Feb 1 1997

Fingerprint

Oligodendroglia
Second Pregnancy Trimester
Spinal Cord
Gene Expression
Pregnancy
Messenger RNA
Glial Fibrillary Acidic Protein
Myelin Sheath
Proteins
2',3'-Cyclic Nucleotide 3'-Phosphodiesterase
Myelin-Associated Glycoprotein
Proteolipids
Myelin Proteins
Myelin Basic Protein
Human Development
Immunoblotting
Neuroglia
Astrocytes
Genes
Reference Values

Keywords

  • central nervous system
  • CNPase
  • glial fibrillary acidic protein
  • human development
  • myelin basic protein
  • myelin-associated glycoprotein
  • myelination

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Oligodendrocyte gene expression in the human fetal spinal cord during the second trimester of gestation. / Grever, William E.; Weidenheim, Karen M.; Tricoche, Marianela; Rashbaum, William K.; Lyman, William D.

In: Journal of Neuroscience Research, Vol. 47, No. 3, 01.02.1997, p. 332-340.

Research output: Contribution to journalArticle

Grever, William E. ; Weidenheim, Karen M. ; Tricoche, Marianela ; Rashbaum, William K. ; Lyman, William D. / Oligodendrocyte gene expression in the human fetal spinal cord during the second trimester of gestation. In: Journal of Neuroscience Research. 1997 ; Vol. 47, No. 3. pp. 332-340.
@article{70ea9c39b67041d180daa81affabcdc8,
title = "Oligodendrocyte gene expression in the human fetal spinal cord during the second trimester of gestation",
abstract = "A comprehensive evaluation of myelination during normal human development is essential to understand the pathology of congenital diseases of white matter. The present study establishes quantitative values for normal oligodendrocyte-specific gene expression during the early stages of myelination in the human fetal spinal cord. Complementary techniques of Northern and immunoblotting were used to determine relative amounts of oligodendrocyte-specific mRNAs and proteins between 12 and 24 gestational weeks. Values were determined for myelin basic protein, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and proteolipid protein. The relative amount of myelin-associated glycoprotein mRNA was also estimated. To compare gene expression between glial cell types, the relative amounts of mRNA and protein were determined for glial fibrillary acidic protein (GFAP), a cell-type specific marker for astrocytes. All oligodendrocyte-specific genes expressed similar developmental kinetics. Between 12 and 15 gestational weeks, less than a five-fold increase was detected in the expression of these genes and their protein products. Between 15 and 22 gestational weeks, the relative amounts of mRNA and protein for the myelin genes increased more than 80- fold. The kinetics of GFAP expression were similar to those of the myelin- associated genes. Absolute values for the increase in mass of the human fetal spinal cord were also obtained. These results provide data that may aid in the neuropathologic assessment and characterization of myelin disorders in the preterm, neonatal, and pediatric spinal cord.",
keywords = "central nervous system, CNPase, glial fibrillary acidic protein, human development, myelin basic protein, myelin-associated glycoprotein, myelination",
author = "Grever, {William E.} and Weidenheim, {Karen M.} and Marianela Tricoche and Rashbaum, {William K.} and Lyman, {William D.}",
year = "1997",
month = "2",
day = "1",
doi = "10.1002/(SICI)1097-4547(19970201)47:3<332::AID-JNR11>3.0.CO;2-3",
language = "English (US)",
volume = "47",
pages = "332--340",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Oligodendrocyte gene expression in the human fetal spinal cord during the second trimester of gestation

AU - Grever, William E.

AU - Weidenheim, Karen M.

AU - Tricoche, Marianela

AU - Rashbaum, William K.

AU - Lyman, William D.

PY - 1997/2/1

Y1 - 1997/2/1

N2 - A comprehensive evaluation of myelination during normal human development is essential to understand the pathology of congenital diseases of white matter. The present study establishes quantitative values for normal oligodendrocyte-specific gene expression during the early stages of myelination in the human fetal spinal cord. Complementary techniques of Northern and immunoblotting were used to determine relative amounts of oligodendrocyte-specific mRNAs and proteins between 12 and 24 gestational weeks. Values were determined for myelin basic protein, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and proteolipid protein. The relative amount of myelin-associated glycoprotein mRNA was also estimated. To compare gene expression between glial cell types, the relative amounts of mRNA and protein were determined for glial fibrillary acidic protein (GFAP), a cell-type specific marker for astrocytes. All oligodendrocyte-specific genes expressed similar developmental kinetics. Between 12 and 15 gestational weeks, less than a five-fold increase was detected in the expression of these genes and their protein products. Between 15 and 22 gestational weeks, the relative amounts of mRNA and protein for the myelin genes increased more than 80- fold. The kinetics of GFAP expression were similar to those of the myelin- associated genes. Absolute values for the increase in mass of the human fetal spinal cord were also obtained. These results provide data that may aid in the neuropathologic assessment and characterization of myelin disorders in the preterm, neonatal, and pediatric spinal cord.

AB - A comprehensive evaluation of myelination during normal human development is essential to understand the pathology of congenital diseases of white matter. The present study establishes quantitative values for normal oligodendrocyte-specific gene expression during the early stages of myelination in the human fetal spinal cord. Complementary techniques of Northern and immunoblotting were used to determine relative amounts of oligodendrocyte-specific mRNAs and proteins between 12 and 24 gestational weeks. Values were determined for myelin basic protein, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and proteolipid protein. The relative amount of myelin-associated glycoprotein mRNA was also estimated. To compare gene expression between glial cell types, the relative amounts of mRNA and protein were determined for glial fibrillary acidic protein (GFAP), a cell-type specific marker for astrocytes. All oligodendrocyte-specific genes expressed similar developmental kinetics. Between 12 and 15 gestational weeks, less than a five-fold increase was detected in the expression of these genes and their protein products. Between 15 and 22 gestational weeks, the relative amounts of mRNA and protein for the myelin genes increased more than 80- fold. The kinetics of GFAP expression were similar to those of the myelin- associated genes. Absolute values for the increase in mass of the human fetal spinal cord were also obtained. These results provide data that may aid in the neuropathologic assessment and characterization of myelin disorders in the preterm, neonatal, and pediatric spinal cord.

KW - central nervous system

KW - CNPase

KW - glial fibrillary acidic protein

KW - human development

KW - myelin basic protein

KW - myelin-associated glycoprotein

KW - myelination

UR - http://www.scopus.com/inward/record.url?scp=0031031670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031031670&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4547(19970201)47:3<332::AID-JNR11>3.0.CO;2-3

DO - 10.1002/(SICI)1097-4547(19970201)47:3<332::AID-JNR11>3.0.CO;2-3

M3 - Article

VL - 47

SP - 332

EP - 340

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 3

ER -